Eric Easom - Oct 31, 2022 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Chief Executive Officer, Director
Signature
/s/ Lucy Day, Attorney-in-Fact for Eric Easom
Stock symbol
ANTX
Transactions as of
Oct 31, 2022
Transactions value $
-$64,625
Form type
4
Date filed
11/2/2022, 08:52 PM
Previous filing
Oct 28, 2022
Next filing
Nov 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Sale -$41.4K -2.69K -29.41% $15.39 6.45K Oct 31, 2022 Direct F1
transaction ANTX Common Stock Sale -$23.3K -1.54K -23.93% $15.07 4.91K Nov 2, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.